Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed.
Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, Szumowski JD, Appa A, Koester K, Dauria EF, McNulty M, Colasanti J, Havlir DV, Gandhi M, Christopoulos KA.
Hickey MD, et al. Among authors: koester k.
J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):280-289. doi: 10.1097/QAI.0000000000003421.
J Acquir Immune Defic Syndr. 2024.
PMID: 38534179